Ads
related to: Skyrizi- Treatment Information
Therapy Info Including Safety
and Clinical Trial Results
- Watch Videos
Explore the Video Library And
Learn More About This Treatment
- Safety Information
Get Safety Information
About This Treatment
- Support And Savings
Visit The Official Website And
Get Resources Your Patients Need
- Register for Info
Enroll for Professional
Updates
- Patient Tools
Get The Right Informational Tools
That May Help You And Your Patients
- Treatment Information
Search results
AbbVie Q1 Preview: Skyrizi and Rinvoq’s launches could help Q1 (NYSE:ABBV)
Seeking Alpha· 3 hours agoAbbVie (ABBV) is set to report Q1 earnings results on April 26th. Analysts expect a profit of $2.26...
Zacks Industry Outlook Highlights Eli Lilly, Novo Nordisk, Merck and AbbVie
Zacks via Yahoo Finance· 5 hours agoNewer immunology medicines, Skyrizi and Rinvoq, are performing extremely well, bolstered by approval...
Nvidia will soar 21% to $1,000 as its new AI chip slams would-be rivals, Morgan Stanley says. It’s...
Fortune via Yahoo Finance· 2 days ago“We believe that growth from ABBV’s ex-Humira business (primarily Skyrizi, Rinvoq, and aesthetics)...
AbbVie (ABBV) to Report Q1 Earnings: What's in the Cards?
Zacks via Yahoo Finance· 3 days agoAbbVie’s top line is being driven by sales of new immunology drugs, Skyrizi and Rinvoq. The Zacks...
What's in Store for These 5 Pharma Bigwigs in Q1 Earnings?
Zacks via Yahoo Finance· 1 day agoThe Zacks Consensus Estimate is pegged at $2.26 per share. AbbVie’s top line is expected to have...
Gear Up for AbbVie (ABBV) Q1 Earnings: Wall Street Estimates for Key Metrics
Zacks via Yahoo Finance· 2 days agoGet a deeper insight into the potential performance of AbbVie (ABBV) for the quarter ended March...
Artisan International Fund Q1 2024 Commentary
Seeking Alpha· 1 day agoArtisan Partners is an independent investment management firm focused on providing high value-added, active investment strategies to sophisticated...
AbbVie (ABBV) to Release Quarterly Earnings on Friday
ETF DAILY NEWS· 15 hours agoAbbVie (NYSE:ABBV – Get Free Report) is scheduled to be issuing its quarterly earnings data before the market opens on Friday, April 26th. Analysts expect the company to announce earnings of ...
AbbVie (NYSE:ABBV) Shares Up 1.8%
ETF DAILY NEWS· 5 days agoAbbVie Inc. (NYSE:ABBV – Get Free Report) shot up 1.8% on Thursday . The company traded as high as $167.44 and last traded at $167.14. BMO Capital Markets raised their price target on shares ...
AbbVie Inc. (NYSE:ABBV) to Post Q1 2024 Earnings of $2.21 Per Share, William Blair Forecasts
ETF DAILY NEWS· 6 days agoAbbVie Inc. (NYSE:ABBV – Free Report) – Research analysts at William Blair issued their Q1 2024 EPS estimates for AbbVie in a research note issued to investors on Wednesday, April 17th. William ...
Ads
related to: Skyrizi